Over halfway through Phase 2 trials. The new restructured board and management are delivering as they said they would.
Considering this is a software plug in to sleep centres with almost zero COGS, the economics of this type of medical technology play is alomst unrivalled.
If FDA approval is given, the company has a clearly defined moat, with a large TAM see exert from above ann(FDA clearance would unlock a significant market opportunity for the Company. It is estimated that 60 million people in the US suffer from poor sleep quality1 and that 75% of people diagnosed with depression suffer from disrupted sleep patterns) and a product with an amazing GP margin.
Seems pretty good value at a MC of only $13m
- Forums
- ASX - By Stock
- Ann: Positive Engagement Meeting with US FDA for MEB-001
Over halfway through Phase 2 trials. The new restructured board...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
|
|||||
Last
3.6¢ |
Change
0.002(5.88%) |
Mkt cap ! $15.99M |
Open | High | Low | Value | Volume |
3.4¢ | 3.6¢ | 3.3¢ | $43.48K | 1.268M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 401896 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 569323 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 401896 | 0.035 |
1 | 5000 | 0.034 |
2 | 112950 | 0.033 |
2 | 260000 | 0.032 |
3 | 185484 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 569323 | 5 |
0.037 | 638977 | 3 |
0.038 | 494900 | 7 |
0.039 | 425000 | 2 |
0.040 | 107529 | 4 |
Last trade - 15.29pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
TRI (ASX) Chart |